Testing effectiveness (Phase 2)UnknownNCT01120002What this trial is testingEfficacy and Safety of Tamibarotene (OAM80) for Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Osaka City University 50
Testing effectiveness (Phase 2)Study completedNCT04491006What this trial is testingATH-1017 in Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer DiseaseDementia of Alzheimer Type LeonaBio 77
Early research (Phase 1)Study completedNCT03008161What this trial is testingMultiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's DiseaseWho this might be right forAlzheimer Disease Proclara Biosciences, Inc. 83
Not applicableStudy completedNCT00297362What this trial is testingThe Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Janssen Cilag Pharmaceutica S.A.C.I., Greece 344
Not applicableStudy completedNCT03328195What this trial is testingVielight Neuro RX Gamma - Feasibility PilotWho this might be right forAlzheimer Disease Vielight Inc. 60
Testing effectiveness (Phase 2)Study completedNCT00104273What this trial is testingRasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)Who this might be right forDementiaAlzheimer's Disease Teva Branded Pharmaceutical Products R&D, Inc. 376
Testing effectiveness (Phase 2)Study completedNCT00498602What this trial is testingStudy Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer Disease Pfizer 160
Post-approval studies (Phase 4)Study completedNCT02444637What this trial is testingOpen Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVDWho this might be right forAlzheimer DiseaseCVA (Cerebrovascular Accident) National Neuroscience Institute 100
Testing effectiveness (Phase 2)Study completedNCT00244322What this trial is testingEffects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Eli Lilly and Company 45
Post-approval studies (Phase 4)Looking for participantsNCT05924425What this trial is testingDaridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer DiseaseWho this might be right forAlzheimer DiseaseInsomnia DisorderSleep University Hospital, Montpellier 62
Testing effectiveness (Phase 2)Study completedNCT01466088What this trial is testingEfficacy, Safety, & Tolerability of AZD3480 Patients With Mild to Moderate Dementia of the Alzheimer's Type (AD)Who this might be right forAlzheimer's Disease Targacept Inc. 386
Large-scale testing (Phase 3)Not Yet RecruitingNCT05809908What this trial is testingTricaprilin Phase 3 ALTER-AD (Alternative-Alzheimer Disease) StudyWho this might be right forAlzheimer Disease Cerecin 535
Large-scale testing (Phase 3)Study completedNCT00348140What this trial is testingRosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 1,468
Early research (Phase 1)Study completedNCT04715750What this trial is testingEvaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific ActivityWho this might be right forAlzheimer DiseaseProgressive Supranuclear Palsy Life Molecular Imaging GmbH 10
Testing effectiveness (Phase 2)Study completedNCT00744978What this trial is testingEvaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease Pfizer 66
Testing effectiveness (Phase 2)Study completedNCT00381238What this trial is testingOpen-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 33
Testing effectiveness (Phase 2)UnknownNCT00154635What this trial is testingEfficacy and Safety Study of DCB-AD1 in Patients With Mild to Moderate Alzheimer's DiseaseWho this might be right forDementia, Alzheimer Type National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT00265148What this trial is testingBrain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 80
Testing effectiveness (Phase 2)Ended earlyNCT01626391What this trial is testingSafety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease TauRx Therapeutics Ltd 9
Early research (Phase 1)Study completedNCT00675090What this trial is testingBridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's DiseaseWho this might be right forAlzheimer's Disease GlaxoSmithKline 28